Confronting consolidation issues: Is this the right move for you ...
Perhaps the best recent example is Peptide Therapeutics' (Cambridge, UK) acquisition of OraVax, effecting the combination of ... Given this trend, what
are the key issues in structuring a merger of two biotechnology companies? ...
http://www.nature.com/bioent/2003/030101/full/nbt0299supp_27...
|
Standard Vaccine Manufacturer Abbreviations
ORA, OraVax, Inc. [abbreviation and/or name superseded: subsidiary of Peptide Therapeutics Group, plc; see PTE]. ORT, Ortho-Clinical Diagnostics [a Johnson
...
http://www.cdc.gov/vaccinesafety/vaxtech/visi/standard_vacci...
|
Bioentrepreneur - Building a Business - Confronting consolidation ...
... example is Peptide Therapeutics' (Cambridge, UK) acquisition of OraVax, ... Given this trend, what are the key issues in structuring a merger of two ...
http://www.nature.com/bioent/building/partnering/012003/full...
|
Standard Vaccine Manufacturer Abbreviations
BioChem Pharma [absorbed by merger into Shire Biologics, a subsidiary of Shire .... OraVax, Inc. [abbreviation and/or name superseded: subsidiary of Peptide
... Peptide Therapeutics Group, plc. PTM. Pitman-Moore, Inc., Pitman-Moore ...
http://www.cdc.gov/vaccinesafety/vaxtech/visi/standard_vacci...
|
BioSpace Life Sciences Company Profiles by Industry
AlumiFuel Power Corporation (Formerly known as Inhibiton Therapeutics) ...... JPT Peptide Technologies GmbH ..... OraVax, Inc. Oraya Therapeutics ...
http://www.biospace.com/company_index.aspx?IndustryId=7...
|
NIP: VISI/Mfg Abbrev (2003-Oct-31)
31 Oct 2003 ... OraVax, Inc. [abbreviation and/or name superseded: subsidiary of Peptide Therapeutics Group, plc; ... PTE, Peptide Therapeutics Group, plc ...
http://www.cdc.gov/nip/visi/prototypes/mfgnames.htm...
|
EMERGING INFECTIOUS DISEASES
synthetic therapeutic substances of traditional Chinese medicines in Taiwan. ...... antigen and protein A-V antigen fusion peptide. Infect. Immun 1994;62:
4192-201. .... OraVax Reports Results from Phase III Trial of HNK20 ...... would
be expected to merge with recovery from the viral illness. ...
http://www.cdc.gov/ncidod/eid/vol5no1/pdf/v5n1.pdf...
|
